Cancer Community at Illinois Faculty Seminar Series
The Cancer Community at Illinois Faculty Seminar Series continues with a session the first week of April.
Thursday, April 6 | 3:00 p.m. - 4:30 p.m.
Health Care Engineering Systems Center (HCESC), Room 1232
(HCESC is in the lower level of the North Campus Parking Deck Building at 1206 W Clark Street, Urbana, IL)
This month's speakers are:
- Rohit Bhargava (Bioengineering)
- Rex Gaskins (Animal Sciences)
- Edward Roy (Pathology)
- T. Kesh Keshavadas (HSESC)
Please RSVP at go.illinois.edu/CancerLectureSeries.
Request for Faculty Achievements and Publications
The Cancer Community at Illinois is publishing a list of faculty achievements from June 2016 to present in the next issue of Pathways. As you know, our community members have a very active record of achievement and publication, which we aim to celebrate.
Please send us the following information for you or your lab:
- Selected Honors and Awards
- Provide the name of the award and the honor granting organization.
- Selected Grants
- Provide the name of the granting organization, the title of the proposal, and the dates indicating the length of the grant.
- In order to render the list manageable, we are allotting no more than five (5) entries per faculty member. If you would like your work to appear in the next Pathways, please select the five publications you would most like to highlight among those you have published during the academic year. Please note that forthcoming publications are not eligible for inclusion this round.
If you have received ANY awards/acknowledgements/honors and/or published books or articles during this time, send the information/citation(s) to email@example.com.
RSVP for the April 19 CSTAR Reception
The CSTAR program will be holding a reception April 19, 2017. This is a great opportunity for faculty, students, and physicians to learn more about the exciting research happening in the CSTAR program.
Carle and Illinois Reception
April 19, 2017
4:00 - 6:00 p.m.
Mills Breast Cancer Center
Carle Houseworth Conference Center (2nd floor)
Please RSVP by Noon on April 14, 2017.
Carle Cancer Research Update Meeting
Join the discussion at the Carle Cancer Research Update Meeting. This week there will be the presentation of four new studies by Dr. Mantha (pancreatic cancer), Dr. Zhao (colon cancer), and Dr. Rowland (neuroendocrine carcinomas, and rectal cancer). Lunch is not served, but you are welcome to bring your own lunch if you would like.
Presentation of Four New Studies
Dr. Mantha (Pancreatic Cancer)
Dr. Zhao (Colon Cancer)
Dr. Rowland (Neuroendocrine Carcinomas and Rectal Cancer)
March 16, 2017
Noon-12:30 p.m. CST
Carle Cancer Center/MBCI-2nd Floor
Houseworth Conference Room
$700K to Change Standards of Care
The Harrington Discovery Institute is accepting Letters of Intent for its 2018 Harrington Scholar-Innovator Award, an annual program that recognizes physician-scientist innovators in the United States whose research has the potential to change standards of care.
The goal of the Harrington Scholar-Innovator Program is to advance physician-scientist-initiated projects aimed at clinical introduction of new medicines (drugs or biologics). The specific focus of eligible projects includes fundamental discovery (elucidation of novel targets and leads) or development of novel drugs or biologics or drug-device combinations.
Grants of up to $700,000 over two years, as well as non-financial support, will be awarded to innovators at major academic medical centers in the U.S. in support of their efforts to advance promising drug discoveries. Selection criteria include innovation, creativity, and potential for impact on human health.
Letters of Intent must be received no later than April 5, 2017. Upon review, selected applicants will be invited to submit a full application by May 31, 2017 See the Harrington Discovery Institute's website for complete program guidelines and application instructions: Complete RFP.
Deadline: April 5, 2017.
| ||Rex Gaskins (right) and graduate student Patricia Wolf. Photo by L. Brian Stauffer|
Study Links Sulfide-Producing Bacteria and Colon Cancer in African-Americans
A new study reveals that African-Americans have measurable differences in the number and type of bacteria that live in the colon—and those differences are related to their higher-than-average colon cancer risk.
The study, reported in the journal Gut, looked at colonic tissue biopsies from 197 African-Americans and 132 non-Hispanic whites collected over a two-year period ending in 2012. The researchers amplified microbial DNA from the samples, then looked at the abundance of various types of microbes.
The study found that African-Americans have more sulfide-producing bacteria in their colon than non-Hispanic whites in the U.S. do. Although these microbes are a normal part of the gut ecosystem, an overabundance of sulfide in the colon can lead to inflammation and can damage DNA, said University of Illinois animal sciences professor Rex Gaskins, who led the new research with Nathan Ellis, who was at the University of Illinois at Chicago at the time of the study. Ellis is the scientific director of the Cancer Biology Research Program at the University of Arizona Cancer Center in Tucson.
Read the full story here.
Visit our Events Calendar for a complete list of upcoming cancer-related activities and events.